Listed

American Healthcare REIT, Inc.

AHRNYSECIK 1632970Real estateFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$634.5m, Q2 FY2026
Operating income$137.2m, Q2 FY2026
Net income$30.6m, Q2 FY2026
American Healthcare REIT, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m416Revenue, Q3 FY2023, three months to 2023-09-30$416.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-13, accession 0001632970-24-000121.Report this figure433Revenue, Q4 FY2023, three months to 2023-12-31$433.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-27, accession 0001193125-26-082692. Derived: 12-month figure less the 9-month figure.Report this figure452Revenue, Q1 FY2024, three months to 2024-03-31$452.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-09, accession 0001632970-25-000042.Report this figure458Revenue, Q2 FY2024, three months to 2024-06-30$458.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-08, accession 0001632970-25-000064.Report this figure477Revenue, Q3 FY2024, three months to 2024-09-30$476.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-07, accession 0001193125-25-272390.Report this figure497Revenue, Q4 FY2024, three months to 2024-12-31$496.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-27, accession 0001193125-26-082692. Derived: 12-month figure less the 9-month figure.Report this figure497Revenue, Q1 FY2025, three months to 2025-03-31$497.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-08, accession 0001193125-26-214678.Report this figure501Revenue, Q2 FY2025, three months to 2025-06-30$501.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-07, accession 0001193125-26-340269.Report this figure532Revenue, Q3 FY2025, three months to 2025-09-30$532.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-07, accession 0001193125-25-272390.Report this figure564Revenue, Q4 FY2025, three months to 2025-12-31$564.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-27, accession 0001193125-26-082692. Derived: 12-month figure less the 9-month figure.Report this figure610Revenue, Q1 FY2026, three months to 2026-03-31$609.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-08, accession 0001193125-26-214678.Report this figure635Revenue, Q2 FY2026, three months to 2026-06-30$634.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-07, accession 0001193125-26-340269.Report this figure
Cost of revenue$m375Cost of revenue, Q3 FY2023, three months to 2023-09-30$374.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-11-13, accession 0001632970-24-000121.Report this figure385Cost of revenue, Q4 FY2023, three months to 2023-12-31$385.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-27, accession 0001193125-26-082692. Derived: 12-month figure less the 9-month figure.Report this figure404Cost of revenue, Q1 FY2024, three months to 2024-03-31$403.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-09, accession 0001632970-25-000042.Report this figure403Cost of revenue, Q2 FY2024, three months to 2024-06-30$402.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-08, accession 0001632970-25-000064.Report this figure417Cost of revenue, Q3 FY2024, three months to 2024-09-30$417.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-07, accession 0001193125-25-272390.Report this figure431Cost of revenue, Q4 FY2024, three months to 2024-12-31$430.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-27, accession 0001193125-26-082692. Derived: 12-month figure less the 9-month figure.Report this figure432Cost of revenue, Q1 FY2025, three months to 2025-03-31$432.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-08, accession 0001193125-26-214678.Report this figure426Cost of revenue, Q2 FY2025, three months to 2025-06-30$426.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-07, accession 0001193125-26-340269.Report this figure455Cost of revenue, Q3 FY2025, three months to 2025-09-30$454.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-07, accession 0001193125-25-272390.Report this figure480Cost of revenue, Q4 FY2025, three months to 2025-12-31$480.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-27, accession 0001193125-26-082692. Derived: 12-month figure less the 9-month figure.Report this figure512Cost of revenue, Q1 FY2026, three months to 2026-03-31$512.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-08, accession 0001193125-26-214678.Report this figure525Cost of revenue, Q2 FY2026, three months to 2026-06-30$524.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-07, accession 0001193125-26-340269.Report this figure
Operating income$m75.1Operating income, Q3 FY2023, three months to 2023-09-30$75.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-13, accession 0001632970-24-000121.Report this figure84.5Operating income, Q4 FY2023, three months to 2023-12-31$84.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-27, accession 0001193125-26-082692. Derived: 12-month figure less the 9-month figure.Report this figure82.2Operating income, Q1 FY2024, three months to 2024-03-31$82.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-09, accession 0001632970-25-000042.Report this figure88.7Operating income, Q2 FY2024, three months to 2024-06-30$88.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-08, accession 0001632970-25-000064.Report this figure93.5Operating income, Q3 FY2024, three months to 2024-09-30$93.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-07, accession 0001193125-25-272390.Report this figure99.1Operating income, Q4 FY2024, three months to 2024-12-31$99.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-27, accession 0001193125-26-082692. Derived: 12-month figure less the 9-month figure.Report this figure94.5Operating income, Q1 FY2025, three months to 2025-03-31$94.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-08, accession 0001193125-26-214678.Report this figure103Operating income, Q2 FY2025, three months to 2025-06-30$103.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-07, accession 0001193125-26-340269.Report this figure106Operating income, Q3 FY2025, three months to 2025-09-30$105.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-07, accession 0001193125-25-272390.Report this figure112Operating income, Q4 FY2025, three months to 2025-12-31$111.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-27, accession 0001193125-26-082692. Derived: 12-month figure less the 9-month figure.Report this figure126Operating income, Q1 FY2026, three months to 2026-03-31$125.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-08, accession 0001193125-26-214678.Report this figure137Operating income, Q2 FY2026, three months to 2026-06-30$137.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-07, accession 0001193125-26-340269.Report this figure
Interest expense$m42.0Interest expense, Q3 FY2023, three months to 2023-09-30$42.0m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-11-13, accession 0001632970-24-000121.Report this figure41.2Interest expense, Q4 FY2023, three months to 2023-12-31$41.2m. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-02-27, accession 0001193125-26-082692. Derived: 12-month figure less the 9-month figure.Report this figure36.4Interest expense, Q1 FY2024, three months to 2024-03-31$36.4m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-05-09, accession 0001632970-25-000042.Report this figure30.6Interest expense, Q2 FY2024, three months to 2024-06-30$30.6m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-08-08, accession 0001632970-25-000064.Report this figure30.4Interest expense, Q3 FY2024, three months to 2024-09-30$30.4m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-07, accession 0001193125-25-272390.Report this figure30.3Interest expense, Q4 FY2024, three months to 2024-12-31$30.3m. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-02-27, accession 0001193125-26-082692. Derived: 12-month figure less the 9-month figure.Report this figure22.9Interest expense, Q1 FY2025, three months to 2025-03-31$22.9m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-08, accession 0001193125-26-214678.Report this figure22.6Interest expense, Q2 FY2025, three months to 2025-06-30$22.6m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-07, accession 0001193125-26-340269.Report this figure20.4Interest expense, Q3 FY2025, three months to 2025-09-30$20.4m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-07, accession 0001193125-25-272390.Report this figure19.8Interest expense, Q4 FY2025, three months to 2025-12-31$19.8m. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-02-27, accession 0001193125-26-082692. Derived: 12-month figure less the 9-month figure.Report this figure18.8Interest expense, Q1 FY2026, three months to 2026-03-31$18.8m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-08, accession 0001193125-26-214678.Report this figure18.6Interest expense, Q2 FY2026, three months to 2026-06-30$18.6m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-07, accession 0001193125-26-340269.Report this figure
Income tax$m0.3Income tax, Q3 FY2023, three months to 2023-09-30$284.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-13, accession 0001632970-24-000121.Report this figure(0.1)Income tax, Q4 FY2023, three months to 2023-12-31−$112.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-27, accession 0001193125-26-082692. Derived: 12-month figure less the 9-month figure.Report this figure0.3Income tax, Q1 FY2024, three months to 2024-03-31$278.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-09, accession 0001632970-25-000042.Report this figure0.7Income tax, Q2 FY2024, three months to 2024-06-30$686.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-08, accession 0001632970-25-000064.Report this figure0.3Income tax, Q3 FY2024, three months to 2024-09-30$263.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-07, accession 0001193125-25-272390.Report this figure0.5Income tax, Q4 FY2024, three months to 2024-12-31$486.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-27, accession 0001193125-26-082692. Derived: 12-month figure less the 9-month figure.Report this figure0.6Income tax, Q1 FY2025, three months to 2025-03-31$604.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-08, accession 0001193125-26-214678.Report this figure0.7Income tax, Q2 FY2025, three months to 2025-06-30$732.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-07, accession 0001193125-26-340269.Report this figure(21.1)Income tax, Q3 FY2025, three months to 2025-09-30−$21.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-07, accession 0001193125-25-272390.Report this figure(2.4)Income tax, Q4 FY2025, three months to 2025-12-31−$2.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-27, accession 0001193125-26-082692. Derived: 12-month figure less the 9-month figure.Report this figure(0.5)Income tax, Q1 FY2026, three months to 2026-03-31−$525.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-08, accession 0001193125-26-214678.Report this figure(0.0)Income tax, Q2 FY2026, three months to 2026-06-30−$3.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-07, accession 0001193125-26-340269.Report this figure
Net income$m(6.0)Net income, Q3 FY2023, three months to 2023-09-30−$6.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-13, accession 0001632970-24-000121.Report this figure(27.4)Net income, Q4 FY2023, three months to 2023-12-31−$27.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-27, accession 0001193125-26-082692. Derived: 12-month figure less the 9-month figure.Report this figure(3.9)Net income, Q1 FY2024, three months to 2024-03-31−$3.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-09, accession 0001632970-25-000042.Report this figure2.0Net income, Q2 FY2024, three months to 2024-06-30$2.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-08, accession 0001632970-25-000064.Report this figure(4.1)Net income, Q3 FY2024, three months to 2024-09-30−$4.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-07, accession 0001193125-25-272390.Report this figure(31.8)Net income, Q4 FY2024, three months to 2024-12-31−$31.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-27, accession 0001193125-26-082692. Derived: 12-month figure less the 9-month figure.Report this figure(6.8)Net income, Q1 FY2025, three months to 2025-03-31−$6.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-08, accession 0001193125-26-214678.Report this figure9.9Net income, Q2 FY2025, three months to 2025-06-30$9.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-07, accession 0001193125-26-340269.Report this figure55.9Net income, Q3 FY2025, three months to 2025-09-30$55.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-07, accession 0001193125-25-272390.Report this figure10.8Net income, Q4 FY2025, three months to 2025-12-31$10.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-27, accession 0001193125-26-082692. Derived: 12-month figure less the 9-month figure.Report this figure23.7Net income, Q1 FY2026, three months to 2026-03-31$23.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-08, accession 0001193125-26-214678.Report this figure30.6Net income, Q2 FY2026, three months to 2026-06-30$30.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-07, accession 0001193125-26-340269.Report this figure
Diluted EPS$ per share(0.09)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-13, accession 0001632970-24-000121.Report this figurenot reported(0.04)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-09, accession 0001632970-25-000042.Report this figure0.01Diluted EPS, Q2 FY2024, three months to 2024-06-30$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-08, accession 0001632970-25-000064.Report this figure(0.03)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-07, accession 0001193125-25-272390.Report this figurenot reported(0.04)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-08, accession 0001193125-26-214678.Report this figure0.06Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-07, accession 0001193125-26-340269.Report this figure0.33Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.33 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-07, accession 0001193125-25-272390.Report this figurenot reported0.13Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-08, accession 0001193125-26-214678.Report this figure0.16Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-07, accession 0001193125-26-340269.Report this figure
Basic EPS$ per share(0.09)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-13, accession 0001632970-24-000121.Report this figurenot reported(0.04)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.04 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-09, accession 0001632970-25-000042.Report this figure0.01Basic EPS, Q2 FY2024, three months to 2024-06-30$0.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-08, accession 0001632970-25-000064.Report this figure(0.03)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.03 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-07, accession 0001193125-25-272390.Report this figurenot reported(0.04)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.04 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-08, accession 0001193125-26-214678.Report this figure0.06Basic EPS, Q2 FY2025, three months to 2025-06-30$0.06 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-07, accession 0001193125-26-340269.Report this figure0.33Basic EPS, Q3 FY2025, three months to 2025-09-30$0.33 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-07, accession 0001193125-25-272390.Report this figurenot reported0.13Basic EPS, Q1 FY2026, three months to 2026-03-31$0.13 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-08, accession 0001193125-26-214678.Report this figure0.16Basic EPS, Q2 FY2026, three months to 2026-06-30$0.16 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-07, accession 0001193125-26-340269.Report this figure

Balance sheet

Cash and equivalents$156.9m, Q2 FY2026
Shareholders' equity$3.69bn, Q2 FY2026
American Healthcare REIT, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m35.2Cash and equivalents, Q3 FY2023, at 2023-09-30$35.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-13, accession 0001632970-24-000121.Report this figure43.4Cash and equivalents, FY2023, at 2023-12-31$43.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-27, accession 0001193125-26-082692.Report this figure77.0Cash and equivalents, Q1 FY2024, at 2024-03-31$77.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-09, accession 0001632970-25-000042.Report this figure52.1Cash and equivalents, Q2 FY2024, at 2024-06-30$52.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-08, accession 0001632970-25-000064.Report this figure67.9Cash and equivalents, Q3 FY2024, at 2024-09-30$67.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-07, accession 0001193125-25-272390.Report this figure76.7Cash and equivalents, FY2024, at 2024-12-31$76.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-07, accession 0001193125-26-340269.Report this figure86.1Cash and equivalents, Q1 FY2025, at 2025-03-31$86.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-08, accession 0001193125-26-214678.Report this figure133Cash and equivalents, Q2 FY2025, at 2025-06-30$133.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-07, accession 0001193125-26-340269.Report this figure147Cash and equivalents, Q3 FY2025, at 2025-09-30$147.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-07, accession 0001193125-25-272390.Report this figure115Cash and equivalents, FY2025, at 2025-12-31$114.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-07, accession 0001193125-26-340269.Report this figure119Cash and equivalents, Q1 FY2026, at 2026-03-31$119.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-08, accession 0001193125-26-214678.Report this figure157Cash and equivalents, Q2 FY2026, at 2026-06-30$156.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-07, accession 0001193125-26-340269.Report this figure
Total assets$m4,589Total assets, Q3 FY2023, at 2023-09-30$4.59bn. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-13, accession 0001632970-23-000101.Report this figure4,578Total assets, FY2023, at 2023-12-31$4.58bn. XBRL concept us-gaap:Assets. 10-K filed 2025-02-28, accession 0001632970-25-000018.Report this figure4,703Total assets, Q1 FY2024, at 2024-03-31$4.70bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-14, accession 0001632970-24-000057.Report this figure4,645Total assets, Q2 FY2024, at 2024-06-30$4.64bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-09, accession 0001632970-24-000085.Report this figure4,677Total assets, Q3 FY2024, at 2024-09-30$4.68bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-13, accession 0001632970-24-000121.Report this figure4,488Total assets, FY2024, at 2024-12-31$4.49bn. XBRL concept us-gaap:Assets. 10-K filed 2026-02-27, accession 0001193125-26-082692.Report this figure4,464Total assets, Q1 FY2025, at 2025-03-31$4.46bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-09, accession 0001632970-25-000042.Report this figure4,507Total assets, Q2 FY2025, at 2025-06-30$4.51bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-08, accession 0001632970-25-000064.Report this figure4,770Total assets, Q3 FY2025, at 2025-09-30$4.77bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-07, accession 0001193125-25-272390.Report this figure5,426Total assets, FY2025, at 2025-12-31$5.43bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-07, accession 0001193125-26-340269.Report this figure5,599Total assets, Q1 FY2026, at 2026-03-31$5.60bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-08, accession 0001193125-26-214678.Report this figure5,704Total assets, Q2 FY2026, at 2026-06-30$5.70bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-07, accession 0001193125-26-340269.Report this figure
Total liabilities$m3,055Total liabilities, Q3 FY2023, at 2023-09-30$3.06bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-13, accession 0001632970-23-000101.Report this figure3,119Total liabilities, FY2023, at 2023-12-31$3.12bn. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-28, accession 0001632970-25-000018.Report this figure2,561Total liabilities, Q1 FY2024, at 2024-03-31$2.56bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-14, accession 0001632970-24-000057.Report this figure2,541Total liabilities, Q2 FY2024, at 2024-06-30$2.54bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-09, accession 0001632970-24-000085.Report this figure2,420Total liabilities, Q3 FY2024, at 2024-09-30$2.42bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-13, accession 0001632970-24-000121.Report this figure2,184Total liabilities, FY2024, at 2024-12-31$2.18bn. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-27, accession 0001193125-26-082692.Report this figure2,159Total liabilities, Q1 FY2025, at 2025-03-31$2.16bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-09, accession 0001632970-25-000042.Report this figure2,044Total liabilities, Q2 FY2025, at 2025-06-30$2.04bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-08, accession 0001632970-25-000064.Report this figure2,050Total liabilities, Q3 FY2025, at 2025-09-30$2.05bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-07, accession 0001193125-25-272390.Report this figure2,066Total liabilities, FY2025, at 2025-12-31$2.07bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-07, accession 0001193125-26-340269.Report this figure2,077Total liabilities, Q1 FY2026, at 2026-03-31$2.08bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-08, accession 0001193125-26-214678.Report this figure1,962Total liabilities, Q2 FY2026, at 2026-06-30$1.96bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-07, accession 0001193125-26-340269.Report this figure
Shareholders' equity$m1,314Shareholders' equity, Q3 FY2023, at 2023-09-30$1.31bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2023-11-13, accession 0001632970-23-000101.Report this figure1,270Shareholders' equity, FY2023, at 2023-12-31$1.27bn. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2025-02-28, accession 0001632970-25-000018.Report this figure1,961Shareholders' equity, Q1 FY2024, at 2024-03-31$1.96bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-05-14, accession 0001632970-24-000057.Report this figure1,933Shareholders' equity, Q2 FY2024, at 2024-06-30$1.93bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-08-09, accession 0001632970-24-000085.Report this figure2,207Shareholders' equity, Q3 FY2024, at 2024-09-30$2.21bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-13, accession 0001632970-24-000121.Report this figure2,261Shareholders' equity, FY2024, at 2024-12-31$2.26bn. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-27, accession 0001193125-26-082692.Report this figure2,262Shareholders' equity, Q1 FY2025, at 2025-03-31$2.26bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-05-09, accession 0001632970-25-000042.Report this figure2,421Shareholders' equity, Q2 FY2025, at 2025-06-30$2.42bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-08, accession 0001632970-25-000064.Report this figure2,678Shareholders' equity, Q3 FY2025, at 2025-09-30$2.68bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-07, accession 0001193125-25-272390.Report this figure3,321Shareholders' equity, FY2025, at 2025-12-31$3.32bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-07, accession 0001193125-26-340269.Report this figure3,482Shareholders' equity, Q1 FY2026, at 2026-03-31$3.48bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-08, accession 0001193125-26-214678.Report this figure3,695Shareholders' equity, Q2 FY2026, at 2026-06-30$3.69bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-07, accession 0001193125-26-340269.Report this figure

Cash flow

Operating cash flow$118.6m, Q2 FY2026
Share repurchases$0, Q4 FY2025
American Healthcare REIT, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m29.1Operating cash flow, Q3 FY2023, three months to 2023-09-30$29.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-13, accession 0001632970-24-000121. Derived: 9-month figure less the 6-month figure.Report this figure25.8Operating cash flow, Q4 FY2023, three months to 2023-12-31$25.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-27, accession 0001193125-26-082692. Derived: 12-month figure less the 9-month figure.Report this figure(6.0)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$6.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-09, accession 0001632970-25-000042.Report this figure59.4Operating cash flow, Q2 FY2024, three months to 2024-06-30$59.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-08, accession 0001632970-25-000064. Derived: 6-month figure less the 3-month figure.Report this figure63.1Operating cash flow, Q3 FY2024, three months to 2024-09-30$63.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-07, accession 0001193125-25-272390. Derived: 9-month figure less the 6-month figure.Report this figure59.5Operating cash flow, Q4 FY2024, three months to 2024-12-31$59.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-27, accession 0001193125-26-082692. Derived: 12-month figure less the 9-month figure.Report this figure60.6Operating cash flow, Q1 FY2025, three months to 2025-03-31$60.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-08, accession 0001193125-26-214678.Report this figure71.5Operating cash flow, Q2 FY2025, three months to 2025-06-30$71.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-07, accession 0001193125-26-340269. Derived: 6-month figure less the 3-month figure.Report this figure107Operating cash flow, Q3 FY2025, three months to 2025-09-30$107.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-07, accession 0001193125-25-272390. Derived: 9-month figure less the 6-month figure.Report this figure55.2Operating cash flow, Q4 FY2025, three months to 2025-12-31$55.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-27, accession 0001193125-26-082692. Derived: 12-month figure less the 9-month figure.Report this figure81.1Operating cash flow, Q1 FY2026, three months to 2026-03-31$81.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-08, accession 0001193125-26-214678.Report this figure119Operating cash flow, Q2 FY2026, three months to 2026-06-30$118.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-07, accession 0001193125-26-340269. Derived: 6-month figure less the 3-month figure.Report this figure
Dividends paid$m16.6Dividends paid, Q3 FY2023, three months to 2023-09-30$16.6m. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-Q filed 2024-11-13, accession 0001632970-24-000121. Derived: 9-month figure less the 6-month figure.Report this figure16.6Dividends paid, Q4 FY2023, three months to 2023-12-31$16.6m. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-K filed 2026-02-27, accession 0001193125-26-082692. Derived: 12-month figure less the 9-month figure.Report this figure16.6Dividends paid, Q1 FY2024, three months to 2024-03-31$16.6m. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-Q filed 2025-05-09, accession 0001632970-25-000042.Report this figure33.0Dividends paid, Q2 FY2024, three months to 2024-06-30$33.0m. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-Q filed 2025-08-08, accession 0001632970-25-000064. Derived: 6-month figure less the 3-month figure.Report this figure33.0Dividends paid, Q3 FY2024, three months to 2024-09-30$33.0m. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-Q filed 2025-11-07, accession 0001193125-25-272390. Derived: 9-month figure less the 6-month figure.Report this figure38.3Dividends paid, Q4 FY2024, three months to 2024-12-31$38.3m. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-K filed 2026-02-27, accession 0001193125-26-082692. Derived: 12-month figure less the 9-month figure.Report this figure39.5Dividends paid, Q1 FY2025, three months to 2025-03-31$39.5m. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-Q filed 2026-05-08, accession 0001193125-26-214678.Report this figure39.9Dividends paid, Q2 FY2025, three months to 2025-06-30$39.9m. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-Q filed 2026-08-07, accession 0001193125-26-340269. Derived: 6-month figure less the 3-month figure.Report this figure41.2Dividends paid, Q3 FY2025, three months to 2025-09-30$41.2m. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-Q filed 2025-11-07, accession 0001193125-25-272390. Derived: 9-month figure less the 6-month figure.Report this figure42.9Dividends paid, Q4 FY2025, three months to 2025-12-31$42.9m. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-K filed 2026-02-27, accession 0001193125-26-082692. Derived: 12-month figure less the 9-month figure.Report this figure46.8Dividends paid, Q1 FY2026, three months to 2026-03-31$46.8m. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-Q filed 2026-05-08, accession 0001193125-26-214678.Report this figure47.6Dividends paid, Q2 FY2026, three months to 2026-06-30$47.6m. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-Q filed 2026-08-07, accession 0001193125-26-340269. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$m0.0Share repurchases, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2024-11-13, accession 0001632970-24-000121. Derived: 9-month figure less the 6-month figure.Report this figure0.3Share repurchases, Q4 FY2023, three months to 2023-12-31$304.0k. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-27, accession 0001193125-26-082692. Derived: 12-month figure less the 9-month figure.Report this figure0.0Share repurchases, Q1 FY2024, three months to 2024-03-31$14.0k. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-05-09, accession 0001632970-25-000042.Report this figure0.0Share repurchases, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-08-08, accession 0001632970-25-000064. Derived: 6-month figure less the 3-month figure.Report this figure0.0Share repurchases, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-11-07, accession 0001193125-25-272390. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-27, accession 0001193125-26-082692. Derived: 12-month figure less the 9-month figure.Report this figure0.0Share repurchases, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-05-09, accession 0001632970-25-000042.Report this figure0.0Share repurchases, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-08-08, accession 0001632970-25-000064. Derived: 6-month figure less the 3-month figure.Report this figure0.0Share repurchases, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-11-07, accession 0001193125-25-272390. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-27, accession 0001193125-26-082692. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported

Shares

Diluted shares (weighted)193.35m, Q2 FY2026
American Healthcare REIT, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares65.8Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3065,819,808 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-13, accession 0001632970-23-000101.Report this figure66.0Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3166,026,173 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-14, accession 0001632970-24-000057.Report this figure66.0Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3066,033,345 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-09, accession 0001632970-24-000085.Report this figure66.0Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3066,048,991 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-13, accession 0001632970-24-000121.Report this figure104Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31104,295,142 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-09, accession 0001632970-25-000042.Report this figure131Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30130,689,889 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-08, accession 0001632970-25-000064.Report this figure134Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30133,732,745 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-07, accession 0001193125-25-272390.Report this figure157Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31156,922,819 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-08, accession 0001193125-26-214678.Report this figure161Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30161,143,556 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-07, accession 0001193125-26-340269.Report this figure170Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30169,802,090 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-07, accession 0001193125-25-272390.Report this figure188Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31187,970,438 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-08, accession 0001193125-26-214678.Report this figure193Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30193,347,757 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-07, accession 0001193125-26-340269.Report this figure

Shares outstanding: 218.00mShares outstanding, period not labelled, at 2026-08-03217,998,775 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-07, accession 0001193125-26-340269.Report this figure at Aug 3, 2026, from the cover of the 10-Q filed Aug 7, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. Listed shows no prices and gives no investment advice.